Health Care·Health Care Services·$10.0B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.84 | N/A | +3.20% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $1.84 | N/A | +3.20% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Overall, management conveyed a cautious optimism about the company's performance. They emphasized the need for continued focus on operational improvements.
Management highlighted the importance of maintaining operational efficiency.
They expressed confidence in their long-term growth strategy.
DaVita Inc reported a better-than-expected EPS for the quarter, which indicates some positive momentum in earnings. However, the stock reacted negatively, declining by 0.61%. This could suggest that investors were looking for more comprehensive revenue details or future guidance, which were not provided.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
ALNYLAM PHARMACEUTIC
May 6, 2013